BI Asset Management Fondsmaeglerselskab A/S
Position in ABBV — AbbVie Inc.
CIK 1778131
KOBENHAVN, G7
Position in ABBV
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$60,845,545
-$37,145,879 QoQ
Shares Held
241,796
-46.3% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.49%
of 13F equity value
Holder Rank
#332
of 4,152 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BI Asset Management Fondsmaeglerselskab A/S holds $648,972,761 across 12 Drug Manufacturers - General names. ABBV ranks #3 (9.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
191,037 | $229,135,528 | |
| 2 | JNJ |
Johnson & Johnson
|
488,378 | $124,033,360 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
241,796 | $60,845,545 | |
| 4 | MRK |
Merck & Co., Inc.
|
468,644 | $60,220,754 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
1,033,357 | $59,542,030 | |
| 6 | GSK |
GSK plc
|
911,826 | $47,797,918 | |
| 7 | AMGN |
Amgen Inc
|
63,977 | $23,167,351 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
181,413 | $22,919,718 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $60,845,545 | 241,796 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $97,991,424 | 450,556 | Shares | Defined | 2026-04-16 | |
| 2025-12-31 | $65,581,428 | 287,021 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $99,021,091 | 427,663 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $79,653,254 | 429,120 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $84,433,626 | 402,986 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $83,999,500 | 472,704 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $37,283,434 | 188,796 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $33,353,950 | 194,461 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $32,736,117 | 179,770 | Shares | Defined | 2024-05-03 | |
| 2023-12-31 | $33,014,188 | 213,036 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $32,975,798 | 221,225 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $27,516,042 | 204,231 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $28,951,951 | 181,665 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $29,729,290 | 183,957 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $19,582,581 | 145,910 | Shares | Defined | 2022-11-07 | |
| 2022-06-30 | $22,013,074 | 143,726 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $23,395,877 | 144,321 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $14,224,311 | 105,054 | Shares | Defined | 2022-02-02 | |
| 2021-09-30 | $13,050,112 | 120,980 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $5,810,083 | 51,581 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $5,722,565 | 52,879 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $12,821,461 | 119,659 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $15,315,637 | 174,856 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $14,027,565 | 142,876 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $10,758,256 | 141,203 | Shares | Defined | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||